Specialist Bio-Nanotechnology Product Development Consultancy Signs Collaborative Agreement with a Top 5 Pharma Company

Bio Nano Consulting (BNC), the specialist bio-nanotechnology product development consultancy, has signed a collaborative agreement with a Top 5 pharma company to develop new assay systems for their product discovery and development.

The agreement is the eighth major contract won by BNC in 2008, and follows the completion in mid December of a second contract with Targanta Therapeutics Corporation, in which BNC used world-leading cantilever-array assay system technology to analyse the mechanism of action of Targanta's novel lipoglycopeptide antibiotic, oritavancin.

Commenting on the new contract, Dr David Sarphie, CEO of Bio Nano Consulting said, "Nanotechnology is finding more and more applications in industry, and BNC is developing a well-deserved reputation within the pharmaceutical, biotech, medtech and healthcare industries for providing novel approaches in research and development. With the unparalleled expertise of scientists at UCL's London Centre for Nanotechnology, the Institute of Biomedical Engineering at Imperial College and the National Physical Laboratory, BNC is ideally placed to offer nanotechnology solutions in these sectors".

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bio Nano Consulting. (2019, February 14). Specialist Bio-Nanotechnology Product Development Consultancy Signs Collaborative Agreement with a Top 5 Pharma Company. AZoNano. Retrieved on March 02, 2024 from https://www.azonano.com/news.aspx?newsID=9560.

  • MLA

    Bio Nano Consulting. "Specialist Bio-Nanotechnology Product Development Consultancy Signs Collaborative Agreement with a Top 5 Pharma Company". AZoNano. 02 March 2024. <https://www.azonano.com/news.aspx?newsID=9560>.

  • Chicago

    Bio Nano Consulting. "Specialist Bio-Nanotechnology Product Development Consultancy Signs Collaborative Agreement with a Top 5 Pharma Company". AZoNano. https://www.azonano.com/news.aspx?newsID=9560. (accessed March 02, 2024).

  • Harvard

    Bio Nano Consulting. 2019. Specialist Bio-Nanotechnology Product Development Consultancy Signs Collaborative Agreement with a Top 5 Pharma Company. AZoNano, viewed 02 March 2024, https://www.azonano.com/news.aspx?newsID=9560.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.